











Dr. Melanie Watson and her daughter, Claire Juliette Watson-Ray 
Melanie Watson, Ph.D.: How 
a Mother’s Love Inspires an
Innovative Medical Solution 
by Megan Ward, Biochemistry Sophomore 
How far would you drive for blood tests? Five minutes? 
Fifteen minutes? How about four hours? 
During her second trimester, Melanie Watson, Ph.D., 
found out that her daughter had Trisomy 18, also known 
as Edward’s syndrome. Three copies of the eighteenth 
chromosome cause this genetic condition and many health 
complications, including heart problems. Most babies with 
Trisomy 18 do not live to see their first birthdays. However, 
Claire Juliette Watson-Ray inherited her mother’s fighting 
spirit. Claire just saw her sixth set of birthday candles. 
Unrelated to her genetic condition, Claire was diagnosed 
with hepatoblastoma, a type of liver cancer, at the age of 
14 months. At the time, her mother, Dr. Melanie Watson, 
worked as an assistant professor of biomedical engineering 
at LeTourneau University in Longview, Texas. Once a week, 
Dr. Watson drove four hours from Longview to Houston for 
Claire’s chemotherapy treatments and sometimes just for
blood tests. 
Standing in a crowded elevator with people cooing over her 
immunosuppressed baby, Dr. Watson thought there had to be 
something she could do. “I’m a biomedical engineer. I can do 
this,” Watson said. There had to be a better way for chronic 
patients to get their blood tested. 
Individuals with diabetes can use various glucose monitoring 
devices to determine their blood glucose levels in real time. 
Engineers have created devices that work with smartphones 
to test these glucose levels. However, the devices are not 
typically available to patients; they are available only to 
physicians. Additionally, these devices are costly. What stops 
engineers from creating a similar device to help chronically ill 
patients test their blood? 
Nothing. Dr. Watson, a three-time graduate from Louisiana 
Tech University, works tirelessly to bring such a product to the 
market. Dr. Watson’s desire to provide the best care possible
for her daughter led her to create a device that works with 
smartphones to provide blood test results in real time. 
Currently, she works as an associate professor of biomedical 
engineering at Trine University, in Angola, Indiana. Both the 
university and her students invest their resources into the 
product. Trine provides funding for Dr. Watson’s project, and 
some of her students contribute their time, aiding in the 
research and development. 
The device uses one drop of blood to provide results for 
simplified complete blood count, blood urea nitrogen (BUN)/ 
creatinine and potassium levels. A drop of blood is placed 
on a cartridge that slides into a smartphone case, and 
the cartridge then takes an image of the drop of blood. 
The cartridge works in tandem with an application on the 
smartphone. This application then uses an algorithm to 
process the images and provide blood test results within 
minutes. 
This device is not meant to replace the need for a physician. 
Rather, Dr. Watson seeks to have these results sent to the 
patient’s designated physician. Simply, she designed the 
device to “enhance the patient/ physician relationship.” She 
hopes this device reduces the amount of in-person blood 
testing from every few days to every two weeks. This less 
frequent in-person blood testing decreases the patient’s 
exposure to other illnesses and decreases costs. 
Depending on partnership agreements, Dr. Watson’s device 
could be out in less than three years, and she seeks to make 
her product available to everyone.
Sources: 
https://ghr.nlm.nih.gov/condition/trisomy-18#genes
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